Axitinib and crizotinib combination therapy inhibits bone loss in a mouse model of castration resistant prostate cancer
Crossref DOI link: https://doi.org/10.1186/1471-2407-14-742
Published Online: 2014-10-02
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Eswaraka, Jeetendra
Giddabasappa, Anand
Han, Guangzhou
Lalwani, Kush
Eisele, Koleen
Feng, Zheng
Affolter, Timothy
Christensen, James
Li, Gang
License valid from 2014-10-02